Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).

Zampetti S, Campagna G, Tiberti C, Songini M, Arpi ML, De Simone G, Cossu E, Cocco L, Osborn J, Bosi E, Giorgino F, Spoletini M, Buzzetti R; NIRAD Study Group.

Eur J Endocrinol. 2014 Dec;171(6):697-704. doi: 10.1530/EJE-14-0342. Epub 2014 Sep 11.

PMID:
25213702
2.

Effect of calcitriol on bone turnover and osteocalcin in recent-onset type 1 diabetes.

Napoli N, Strollo R, Pitocco D, Bizzarri C, Maddaloni E, Maggi D, Manfrini S, Schwartz A, Pozzilli P; IMDIAB Group.

PLoS One. 2013;8(2):e56488. doi: 10.1371/journal.pone.0056488. Epub 2013 Feb 20.

3.

Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes.

Nicolucci A, Cucinotta D, Squatrito S, Lapolla A, Musacchio N, Leotta S, Vitali L, Bulotta A, Nicoziani P, Coronel G; QuoLITy Study Group.

Nutr Metab Cardiovasc Dis. 2009 Jan;19(1):45-53. doi: 10.1016/j.numecd.2007.12.005. Epub 2008 May 1.

PMID:
18450436
4.

The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control.

Petrone A, Spoletini M, Zampetti S, Capizzi M, Zavarella S, Osborn J, Pozzilli P, Buzzetti R; Immunotherapy Diabetes (IMDIAB) Group.

Diabetes Care. 2008 Jun;31(6):1214-8. doi: 10.2337/dc07-1158. Epub 2008 Feb 5.

PMID:
18252906
5.

Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell function.

Pitocco D, DiStasio E, Crinò A, Manfrini S, Guglielmi C, Visalli N, Suraci C, Matteoli MC, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group.

Horm Metab Res. 2008 Jan;40(1):66-8. Epub 2007 Dec 18. No abstract available.

PMID:
18085501
6.

The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI).

Pitocco D, Crinò A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, Anguissola GB, Visalli N, Suraci C, Matteoli MC, Patera IP, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group.

Diabet Med. 2006 Aug;23(8):920-3.

PMID:
16911633
7.

A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus.

Crinó A, Schiaffini R, Ciampalini P, Suraci MC, Manfrini S, Visalli N, Matteoli MC, Patera P, Buzzetti R, Guglielmi C, Spera S, Costanza F, Fioriti E, Pitocco D, Pozzilli P; IMDIAB Group.

J Pediatr Endocrinol Metab. 2005 Aug;18(8):749-54.

PMID:
16200840
8.

A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX).

Crinò A, Schiaffini R, Manfrini S, Mesturino C, Visalli N, Beretta Anguissola G, Suraci C, Pitocco D, Spera S, Corbi S, Matteoli MC, Patera IP, Manca Bitti ML, Bizzarri C, Pozzilli P; IMDIAB group.

Eur J Endocrinol. 2004 May;150(5):719-24.

9.

A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8).

Pozzilli P, Crinò A, Schiaffini R, Manfrini S, Fioriti E, Coppolino G, Pitocco D, Visalli N, Corbi S, Spera S, Suraci C, Cervoni M, Matteoli MC, Patera IP, Ghirlanda G; IMDIAB Group.

Diabetes Technol Ther. 2003;5(6):965-74.

PMID:
14709198
10.

Identification of novel WFS1 mutations in Italian children with Wolfram syndrome.

Tessa A, Carbone I, Matteoli MC, Bruno C, Patrono C, Patera IP, De Luca F, Lorini R, Santorelli FM.

Hum Mutat. 2001 Apr;17(4):348-9.

PMID:
11295831
11.

No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.

Pozzilli P, Pitocco D, Visalli N, Cavallo MG, Buzzetti R, Crinò A, Spera S, Suraci C, Multari G, Cervoni M, Manca Bitti ML, Matteoli MC, Marietti G, Ferrazzoli F, Cassone Faldetta MR, Giordano C, Sbriglia M, Sarugeri E, Ghirlanda G.

Diabetologia. 2000 Aug;43(8):1000-4.

PMID:
10990077
12.

T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitus.

Dotta F, Dionisi S, Viglietta V, Tiberti C, Matteoli MC, Cervoni M, Bizzarri C, Marietti G, Testi M, Multari G, Lucentini L, Di Mario U.

Eur J Endocrinol. 1999 Sep;141(3):272-8.

13.

A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI).

Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, Mesturino C, Fiori R, Lucentini L, Matteoli MC, Crinò A, Corbi S, Spera S, Teodonio C, Paci F, Amoretti R, Pisano L, Suraci C, Multari G, Sulli N, Cervoni M, De Mattia G, Faldetta MR, Boscherini B, Pozzilli P, et al.

Diabetes Metab Res Rev. 1999 May-Jun;15(3):181-5.

PMID:
10441040
14.

Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study)

Pozzilli P, Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, Mesturino C, Fiori R, Romiti A, Giovannini C, Lucentini L, Matteoli MC, Crinò A, Teodonio C, Paci F, Amoretti R, Pisano L, Suraci C, Multari G, Suppa M, Sulli N, De Mattia G, Faldetta MR.

Eur J Endocrinol. 1997 Sep;137(3):234-9. Erratum in: Eur J Endocrinol 1997 Nov;137(5):558. Suraci MT [corrected to Suraci C].

15.

Incidence of insulin-dependent diabetes mellitus among Sardinian-heritage children born in Lazio region, Italy.

Muntoni S, Fonte MT, Stoduto S, Marietti G, Bizzarri C, Crinò A, Ciampalini P, Multari G, Suppa MA, Matteoli MC, Lucentini L, Sebastiani LM, Visalli N, Pozzilli P, Boscherini B, Muntoni S.

Lancet. 1997 Jan 18;349(9046):160-2.

PMID:
9111539
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk